TNFR2 是人白血病中 RIP1 依赖细胞死亡所必需的
该研究探讨人白血病对 Smac 模拟物(SM)敏感性的分子机制。研究发现 TNFR2 mRNA 表达与 SM 敏感性相关,CRISPR/Cas9 实验表明 TNFR2 和 TNFR1(而非配体 TNF-α)对 SM 应答至关重要,TNFR2 促进 RIP1/TNFR1 死亡信号复合物形成,诱导 RIP1 磷酸化及 RIP1 依赖的凋亡与坏死性凋亡。
要点
- TNFR2 mRNA 表达与原发性人白血病对 SM 的敏感性相关。
- TNFR2 和 TNFR1 而非 TNF-α 是 SM 应答所必需的。
- TNFR2 促进 RIP1/TNFR1 死亡复合物形成及 RIP1 依赖细胞死亡。
核心结论
- TNFR2 通过促进 RIP1/TNFR1 死亡信号复合物形成,在人白血病 RIP1 依赖细胞死亡中起关键作用。
研究设计与样本
- 使用原发性人白血病样本及 CRISPR/Cas9 功能遗传实验研究 SM 敏感性的分子机制。
主要发现
- TNFR2 mRNA 表达与原发性人白血病对 SM 的敏感性相关。
- TNFR2 和 TNFR1 而非 TNF-α 对 SM 应答是必需的,揭示配体非依赖的 TNFR1-TNFR2 相互作用。
- 淋巴毒素等其它 TNFR 配体对 SM 敏感性非必需。
- TNFR2 促进含 RIP1/TNFR1 的死亡信号复合物形成,诱导 RIP1 磷酸化及 RIP1 依赖的凋亡和坏死性凋亡。
临床怎么用
- TNFR2 表达或可辅助识别对 RIP1 依赖细胞死亡敏感的白血病,为个体化治疗提供依据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Despite major advances in the treatment of patients with acute lymphoblastic leukemia in the last decades, refractory and/or relapsed disease remains a clinical challenge, and relapsed leukemia patients have an exceedingly dismal prognosis. Dysregulation of apoptotic cell death pathways is a leading cause of drug resistance; thus, alternative cell death mechanisms, such as necroptosis, represent an appealing target for the treatment of high-risk malignancies. We and other investigators have shown that activation of receptor interacting protein kinase 1 (RIP1)-dependent apoptosis and necroptosis by second mitochondria derived activator of caspase mimetics (SMs) is an attractive antileukemic strategy not currently exploited by standard chemotherapy. However, the underlying molecular mechanisms that determine sensitivity to SMs have remained elusive. We show that tumor necrosis factor receptor 2 (TNFR2) messenger RNA expression correlates with sensitivity to SMs in primary human leukemia. Functional genetic experiments using clustered regularly interspaced short palindromic repeats/Cas9 demonstrate that TNFR2 and TNFR1, but not the ligand TNF-α, are essential for the response to SMs, revealing a ligand-independent interplay between TNFR1 and TNFR2 in the induction of RIP1-dependent cell death. Further potential TNFR ligands, such as lymphotoxins, were not required for SM sensitivity. Instead, TNFR2 promotes the formation of a RIP1/TNFR1-containing death signaling complex that induces RIP1 phosphorylation and RIP1-dependent apoptosis and necroptosis. Our data reveal an alternative paradigm for TNFR2 function in cell death signaling and provide a rationale to develop strategies for the identification of leukemias with vulnerability to RIP1-dependent cell death for tailored therapeutic interventions.
引用
- Aguadé-Gorgorió J, McComb S, Eckert C, et al. TNFR2 is required for RIP1-dependent cell death in human leukemia. Blood Adv. 2020. PMID: 33027529. doi:10.1182/bloodadvances.2019000796
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。